aneuploidy Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Last year, the company processed more than 1 million tests, most of them for its reproductive health business, but interest in Prospera and Signatera is growing. UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Several analysts said that the decision by UHC, the largest private payor in the US, will especially benefit Natera. Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all. Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Sep 21, 2020 Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Aug 17, 2020 ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk Aug 5, 2020 Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business Jul 28, 2020 Yourgene Health Records £2.3M Net Loss for Fiscal Year 2020 Jul 13, 2020 Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia Jul 9, 2020 Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 3, 2020 Sperm Single-Cell Sequencing Study Offers Insight Into Meiotic Variation May 12, 2020 Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal May 6, 2020 Natera Q1 Revenues Grow 41 Percent Apr 20, 2020 Yourgene Health Fiscal 2020 Revenues Up 86 Percent Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Mar 10, 2020 Yourgene Health Acquiring French Distributor of NIPT Test for up to €4.1M Dec 17, 2019 PerkinElmer Aims to Attract Vanadis NIPT Customers Through Service, Validation Studies Premium Dec 11, 2019 Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing Premium Dec 2, 2019 Yourgene Health Revenues Nearly Double in H1 of FY2019 Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.